Chase Carey

Director Chase Carey sold 100,000 shares at blended $90.28, retains 574,331 via options; 5 consecutive prior FWONK sales all well-timed 90-day.

Chase Carey executed 2 separate sales totaling 100,000 shares for $9,028,150.85 at a blended average price of $90.28. His non-derivative holdings decline from 194,356 to 94,356 shares post-transaction, but he retains 574,331 shares through outstanding stock options, maintaining material exposure to FWONK. This is his 5th consecutive transaction at this ticker within recent months, and notably, all 5 prior sales at FWONK proved well-timed at the 90-day mark, with declines ranging from -5.5% to -16.4%. His cross-ticker track record shows a 90% well-timed sell rate with average 90-day returns of -10.5%, indicating a measurable pattern of selling ahead of downturns. At the time of this filing, FWONK trades -16.7% from its 52-week high of $109.36, suggesting the company's stock has retreated considerably since his prior sales windows.

FWONK Director Carey Chase sold 167,036 shares for $16.1M on Dec 16-17 at $96.37 avg, reducing stake by 63.9%

Carey Chase executed 4 separate sales totaling 167,036 shares for $16,096,909.80 over two trading days at an average price of $96.37, eliminating 63.9% of his pre-transaction holdings (from 261,392 to 94,356 shares). His prior trades at FWONK show consistent post-sale declines: the most recent November sells posted 30-day losses ranging from -8.5% to -10.5%, while his one measurable 90-day outcome (May 2025 sale) posted a -1.3% return. The company's fundamentals present challenges: annual revenue contracted -70.8% year-over-year, net income was $13.0M on $1.1B quarterly revenue, and the full fiscal year was unprofitable with a P/E of 505.68. The large liquidation of insider stock, combined with the director's historical pattern of selling before further declines at this ticker, warrants tracking to determine whether the post-sale price action reflects deteriorating business conditions.

Carey Chase sells 81,006 shares (46.5% reduction) for $8,334,321.91 at FWONK; stock -8.8% from 52w high, company -70.8% YoY revenue, unprofitable FY.

Director Carey Chase executed 2 separate sales totaling 81,006 shares for $8,334,321.91, reducing holdings from 174,108 to 93,102 shares. The sales occurred at $103.29 and $102.50 on 2025-11-12, yet the stock currently trades at $98.81, down 4.6% over 30 days and 8.8% from its 52-week high of $108.33. The company context is material: annual revenue declined 70.8% year-over-year, the company was unprofitable over its most recent full fiscal year with only $13,000,000.00 in net income on $1,085,000,000.00 quarterly revenue, and the P/E ratio stands at 520.05. While Chase's cross-ticker track record shows a 50.00% well-timed sell rate with average 90-day returns of 0.1%, his same-ticker history at FWONK shows mixed outcomes (1 of 2 prior measurable sells were well-timed at the 90-day mark). This large, discretionary reduction of director holdings in a highly leveraged valuation context warrants investor scrutiny of the company's operational trajectory.

Director Carey Chase sells 109,121 shares for $11,189,254.83, reducing holdings by 54.0%

Director Carey Chase executed 2 separate sales totaling 109,121 shares for $11,189,254.83 on 2025-11-10, reducing his holdings from 202,223 shares to 93,102 shares. The sales were priced at $103.12 and $102.48, near the 52-week high of $108.33. Fundametals show the company faces significant headwinds: revenue declined by -70.8% year-over-year, net income was negative over the most recent full fiscal year, and the P/E ratio is 534.79 (reflecting minimal earnings). At the same-ticker level, prior sells on 2025-05-13 and 2025-05-12 posted mixed 90-day outcomes (+1.5% and -1.3%), indicating an inconsistent pattern of sale timing at this specific company. The current price of $101.61 sits near the transaction prices, and broader context shows the insider's cross-ticker track record includes a 50% well-timed rate on prior sells with an average 90-day return of 0.1%, neither compelling as evidence of prescience nor concern.

Director Carey Chase sold 150,000 shares (61.7% of holdings) for $14,367,895 at FWONK amid -70.8% revenue collapse and P/E of 510

Director Carey Chase executed 2 separate sales totaling 150,000 shares for $14,367,895 on May 12–13, 2025, reducing his stake from 243,102 shares to 93,102 shares. This represents a -61.7% reduction in holdings at blended price of $95.79, occurring as Liberty Media's fundamentals deteriorated sharply: annual revenue declined -70.8% and the company posted negative full-year net income with a current P/E of 510 (driven by near-zero profitability). The scale of this reduction—liquidating roughly two-thirds of a director's position—stands in contrast to recent stock strength (30-day change: +23.5%) and occurs well above the 52-week low of $68.95, suggesting the execution took advantage of elevated valuations despite deteriorating underlying business performance.